Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
Saved in:
| Title: | Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer. |
|---|---|
| Authors: | Woodman N; Breast Research Pathology, King's College London, Guy's Hospital, London, UK., Pinder SE; Breast Research Pathology, King's College London, Guy's Hospital, London, UK., Tajadura V; Breast Cancer Biology, Research Oncology, King's College London, Guy's Hospital, London, UK., Le Bourhis X; University of Lille, INSERM, U908 - CPAC, Cell Plasticity and Cancer, Lille, Villeneuve d'Ascq, France., Gillett C; Breast Research Pathology, King's College London, Guy's Hospital, London, UK., Delannoy P; University of Lille, CNRS, UMR 8576 - UGSF, Unit of Structural and Functional Glycobiology, Lille, Villeneuve d'Ascq, France., Burchell JM; Breast Cancer Biology, Research Oncology, King's College London, Guy's Hospital, London, UK., Julien S; University of Lille, INSERM, U908 - CPAC, Cell Plasticity and Cancer, Lille, Villeneuve d'Ascq, France. |
| Source: | International journal of oncology [Int J Oncol] 2016 Jul; Vol. 49 (1), pp. 265-75. Date of Electronic Publication: 2016 May 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
